Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
Status:
Completed
Trial end date:
2019-05-14
Target enrollment:
Participant gender:
Summary
In this multi-center, randomized, double-blind, active-controlled, phase II non-inferiority
study, we aimed to test the non-inferiority of evogliptin vs linagliptin in terms of
reduction of albuminuria at week 24 from baseline in patients with type 2 diabetes having
renal insufficiency.